Effect of Tamoxifen and Estrogen Treatment on the Radiosensitivity of MCF-7 Breast Cancer Cells

Oncology Research and Treatment

Volumn 19, Issue 5, 1996, Pages 430-434

  Bohning K ^a   Busch, M ^b   Rave Frank M ^a   Duhmke E ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Estrogen; Radiotherapy; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; HUMAN; HUMAN CELL; RADIATION; RADIOSENSITIVITY; X RAY;

EID: 0029807680     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218846     Document Type: Article

References (22)

1. Fisher B, Bauer M, Margolesc R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerman L, Lerner H, Glass A, Shibata H, Deckers P, Kctcham A, Oishi R, Russell I: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer, N Engl J Med 1985:312:665-673.
2. Veronesi U, Zucali R, Luini A: Local control and survival in early breast cancer: The Milan trial, Int J Radial Oncol Biol Phys 1986:12:717-720.
3. Sarrazin D, Le MG, Fontaine MF, Arriagida R: Ten-year results of a randomized trial comparing a conservative treatment and mastectomy in early breast cancer, Radiother Oncol 1989:14:177-182.
4. Rauschecker HF, Gatzemeier W, Sauer R, Seegen-schmicdt MH, Schauer A, Ummenhofer L, Sauerbrei W, Schmoor L, Schumacher M: Erste Ergebnisse des Projektes der Deutschen Brustkrebs-Studiengruppe (GBSG) zur «Brusterhaltenden Therapie des kleinen Mammacarcinoms», Chirurg 1992:63:495-500.
5. Fletcher GH: Textbook of Radiotherapy, Philadelphia, Lea and Febiger, 1980. pp 529.
6. Clarke R, Lippman ME: Acquisition of antiestrogen resistance in breast cancer; in Teicher BA (ed): Drug Resistance in Oncology, New York, Marcel Dekker, 1992. pp 501-536.
7. Osborne CK, Boldt DH, Estrada P: Human breast cancer cell cycle synchronizations by estrogens and antiestrogens in culture, Cancer Res 1984:44: 1433-1439.
8. Sutherland RL, Hall RE, Taylor IW: Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing cells and plateau-phasc cells, Cancer Res 1983;43:3998-4006.
9. Reddel RR, Sutherland RL: Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro, Cancer Res 1987:47:5323-5329.
10. Sinclair WK, Morton RA: X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells, Radiat Res 1966:29:450-474.
11. Wazer DE, Tercilla OF, Lin PS, Schmidt-Ullrich RK: Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17b-estradiol and tamoxifen, Br J Radiol 1989:62:1079-1083.
12. Wazer DE, Joyce M, Chan W, Gcwirtz D, Lin P-S, Solares G, Schmidt-Ullrich RK: Effects of tamoxifen on the radiosensitivity of hormonally responsive and unresponsive carcinoma cells, Radiat Oncol Invest 1993:1:20-28.
13. Mulcahy RT, Sarkaria JN, Johnson DA, Fowler JF, Jordan VC Miller E: The effect of tamoxifen on the radiation sensitivity of MCF-7 breastcarcinoma cells and or, tumor kinetics of MCF-7 xenografts: A model for evaluating the role of proliferation on tumor response to fractionated irradiation, Program Abstr, 4th Int, Conf, Dose, Time, and Fractionation in Radiation Oncology; University of Wisconsin, Madison WI 1992. pp 65.
14. Coezy E, Borgna JL, Rochefort H: Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth, Cancer Res 1982;42:317-323.
15. lliakis G: Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation, Int J Radiat Biol 1988;53:541-584.
16. Fisher B, Costantino J, Redmond C, Brown A, Wolmark N, Wittcliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Gcggic P, Campbell P, Elias GE, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors, N Engl J Med 1989:320:479-484.
17. Ryden S, Fernö M, Möller T, Aspegren K, Bcrgljung L, Killander D, Landberg T: Long-term effects of adjuvant tamoxifen and/or radiotherapy, Acta Oncol 1992;31:271-274.
18. Overgaard M, Juul-Christensen J, Johansen H, Nybo-Rasmussen A, Brincker H, Kooy P vd, Frederiksen PL, Laurscn F, Panduro J, Sorensen NE, Gadeberg CC, Hjelm-Hansen M, Overgaard J, West Andersen K, Zedeler K: Postmastectomy irradiation in high-risk breast cancer patients - present status of the Danish Breast Cancer Cooperative Group trials, Acta Oncol 1988;27:707-717.
19. Mouridsen HT, Rose C, Overgaard M, Dombernowsky P, Panduro J, Thorpe S, Bruun-Rasmussen B, Blichert-Toft M, West Andersen K: Adjuvant treatment of postmenopausal patients with high-risk primary breast cancer - results from the Danish adjuvant trials DBCG 77 c and 82 c, Acta Oncol 1988;27:699-705.
20. Kantorowitz DA, Thompson HJ, Furmanski P: Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma, Int J Radiat Oncol Biol Phys 1993;26:89-94.
21. Blazek ER, Graybill J: Tamoxifen both radiosensitizes and increases DNA initial double-strand break yield in MCF-7. but not MDA-MB-231. breast cancer cells, Int J Radiat Oncol Biol Phys 1994; 15(suppl):307.
22. Reddel RR, Murphy LC, Sutherland RL; Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro, Cancer Res 1983;43:4618-4624.